Antibiotic resistance is emerging as a critical threat to surgical care worldwide, making even routine operations increasingly dangerous. Experts warn that the loss of effective antibiotics could undermine decades of medical progress, leading to life-threatening infections after surgery. Drug-resistant bacterial infections were directly responsible for an estimated 1.27 million deaths globally in 2019 and were associated with nearly 4.95 million deaths that year.[ndtv+5]
Routine Procedures Now Riskier
Procedures once considered safe, such as appendix removals, Caesarean sections, and knee replacements, are now facing increased risks.When bacteria become resistant to common antibiotics, infections from these routine operations become much harder to treat. This can result in longer hospital stays, the need for repeat surgeries, admissions to intensive care, and, in some cases, death.Dr. Aparna Chakravarty, Professor of Pediatric Infectious Disease at Amrita Hospital, Faridabad, stated that modern surgery relies heavily on antibiotics to prevent and treat infections.She added that the rapid rise of antibiotic resistance is changing this reality.[ndtv+3]
The World Health Organization (WHO) identifies antimicrobial resistance (AMR) as one of the top global public health and development threats.A recent WHO report, released in October 2025, found that one in six bacterial infections worldwide in 2023 were resistant to standard antibiotic treatments.Data from over 100 countries shows resistance rates are climbing between 5% and 15% annually.This trend threatens the safety of various medical interventions, including surgery, chemotherapy, and organ transplantation.[ndtv+9]
Surgical site infections (SSIs) are among the most common healthcare-associated infections.In low and middle-income countries, SSIs affect up to 11% of patients undergoing surgery.The global incidence of SSIs ranges from 3% to 50%, depending on the type of surgery.For instance, the incidence of Caesarean section SSIs is estimated at 5.6% globally, rising to 11.9% in African regions.[business-standard+4]
Economic Burden Mounts Globally
The economic consequences of antibiotic resistance are substantial. Globally, AMR could lead to an additional $1 trillion in healthcare costs by 2050.It could also cause $1 trillion to $3.4 trillion in gross domestic product (GDP) losses per year by 2030.A 2019 estimate placed global hospital costs associated with antibiotic resistance at around $693 billion.[who+2]
In the United States alone, more than 2.8 million antimicrobial-resistant infections occur each year.These infections cause over 35,000 deaths annually.If infections from Clostridioides difficile (C. diff), a bacterium often associated with antibiotic use, are included, the U.S. toll rises to over 3 million infections and 48,000 deaths.The estimated national cost to treat infections caused by six frequently found antimicrobial-resistant germs in healthcare settings is more than $4.6 billion each year.Some reports indicate the total annual expenses related to AMR in the U.S. could be as high as $55 billion.[2minutemedicine+7]
During the COVID-19 pandemic, six types of bacterial antimicrobial-resistant hospital-onset infections in the U.S. increased by a combined 20% compared to pre-pandemic levels.These rates remained above pre-pandemic levels in 2022.The Centers for Disease Control and Prevention (CDC) highlights that antibiotic resistance is a critical global public health threat.[cdc+2]
Urgent Action Needed to Preserve Antibiotics
Experts point to the overuse and indiscriminate use of antibiotics as primary drivers of resistance.Surgeons note that while antibiotics are crucial for preventing surgical site infections, their excessive use has fueled resistance.Patients often expect to continue antibiotics for several days after surgery, despite international guidelines recommending against it for most clean surgical procedures.[business-standard+8]
Hospitals are now forced to adopt stricter antibiotic stewardship practices.These practices include promoting evidence-based antibiotic selection, appropriate timing of antibiotics before surgery, and continuous monitoring of prescribing patterns.The goal is to minimize unnecessary antibiotic exposure without compromising patient safety.[business-standard+2]
Stronger infection control measures are also essential. These include diligent hand hygiene, isolating colonized or infected patients, and thorough environmental cleaning in healthcare settings.The WHO's "Global Guidelines for the Prevention of Surgical Site Infection" recommend that antibiotics be used only to prevent infections before and during surgery, not afterwards.These guidelines, developed by 20 leading experts, offer 29 concrete recommendations to save lives and halt the spread of antibiotic resistance.[ndtv+6]
Public awareness and education play a vital role in combating this threat.Patients need to understand that preserving the effectiveness of existing antibiotics is everyone's responsibility.Multidisciplinary collaboration among healthcare professionals, including surgeons, anaesthetists, nurses, and infectious disease specialists, is also paramount to optimize antibiotic use.[ndtv+8]
The world faces a crisis in the development of new antibiotics.Only 27 new antibiotics are in late-stage trials worldwide, and most are minor modifications of existing drugs.Urgent investment in research and development for novel vaccines, diagnostics, and medicines is critical to address this growing health emergency.Without effective antibiotics, the ability to perform life-saving surgeries safely will diminish, pushing modern medicine back to a much riskier era.[who+7]
